BRIDGEWAY CAPITAL MANAGEMENT, LLC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 60 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 11.10 and the average weighting 1.7%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$554,000
-51.7%
346,4640.0%0.01%
-36.4%
Q3 2018$1,147,000
+46.5%
346,4640.0%0.01%
+37.5%
Q2 2018$783,000
-22.1%
346,4640.0%0.01%
-27.3%
Q1 2018$1,005,000
+3.9%
346,4640.0%0.01%
+10.0%
Q4 2017$967,000
-23.6%
346,4640.0%0.01%
-28.6%
Q3 2017$1,265,000
+23.7%
346,464
-24.8%
0.01%
+16.7%
Q2 2017$1,023,000
+276.1%
460,9640.0%0.01%
+300.0%
Q1 2017$272,000
+9.2%
460,9640.0%0.00%0.0%
Q4 2016$249,000
-45.6%
460,964
-10.3%
0.00%
-57.1%
Q3 2016$458,000
-7.3%
514,0510.0%0.01%
-12.5%
Q2 2016$494,000
+70.9%
514,051
+63.7%
0.01%
+60.0%
Q1 2016$289,000
-27.0%
314,0510.0%0.01%
-28.6%
Q4 2015$396,000
+68.5%
314,051
+61.5%
0.01%
+40.0%
Q3 2015$235,000
-30.5%
194,5000.0%0.01%
-28.6%
Q2 2015$338,000
+19.9%
194,5000.0%0.01%
+16.7%
Q1 2015$282,000
+86.8%
194,500
+8.1%
0.01%
+100.0%
Q4 2014$151,000
-24.5%
180,0000.0%0.00%
-40.0%
Q3 2014$200,000
+263.6%
180,000
+500.0%
0.01%
+400.0%
Q2 2014$55,000
-94.8%
30,000
-94.8%
0.00%
-96.9%
Q4 2013$1,061,000
-11.2%
580,0000.0%0.03%
-22.0%
Q3 2013$1,195,000
+8.6%
580,000
+31.8%
0.04%
-6.8%
Q2 2013$1,100,000440,0000.04%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Deer VI & Co. LLC 675,242$2,465,000100.00%
New Leaf Venture Partners, L.L.C. 2,340,673$8,543,0003.96%
RA Capital Management 11,328,646$41,350,0003.74%
NEA Management Company, LLC 16,362,694$59,724,0002.09%
Avoro Capital Advisors LLC 4,806,249$17,543,0001.36%
683 Capital Management, LLC 2,515,810$9,183,0000.96%
SPHERA FUNDS MANAGEMENT LTD. 1,400,000$5,110,0000.73%
Perceptive Advisors 6,830,232$25,110,0000.48%
EAM Investors, LLC 785,338$2,866,0000.38%
Polar Capital LLP 4,129,238$15,072,0000.17%
View complete list of AVEO PHARMACEUTICALS INC shareholders